ResMed Inc. RMD

222.00 0.11 0.05% as of 25 Sep
Market cap
$31.9B
P/E
21.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

ResMed Inc. (RMD) P/S ratio

As of 25 September 2026, ResMed Inc. (RMD) trades at a P/S ratio of 5.7×. Over the past ten years it has ranged from 4.1× (January 2016) to 13.5× (September 2021); the current reading is higher than 31% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2026 5.0× (31.80%)
FY2025 7.4× 25.39%
FY2024 5.9× (22.75%)
FY2023 7.6× (11.26%)
FY2022 8.6× (23.63%)
FY2021 11.2× 19.57%
FY2020 9.4× 37.93%
FY2019 6.8× 7.33%
FY2018 6.3× 18.87%
FY2017 5.3× 10.44%

Quarterly

Period P/S ratio Change
Jun 2026 5.0× (14.86%)
Mar 2026 5.9× (9.47%)
Dec 2025 6.5× (14.50%)
Sep 2025 7.6× 3.48%
42 more quarters

Against its own ten years

Low 4.1× High 13.5×
Ten-year median 6.7×
Current reading's percentile 31

P/S ratio against peers

Company P/S ratio
MDLN Medline Inc. compare 1.0×
BAX Baxter International Inc. compare 1.1×
SOLV Solventum Corporation compare 1.9×
BDX Becton, Dickinson and Company compare 2.3×
COO The Cooper Companies, Inc. compare 2.5×
ALC Alcon compare 2.9×
RMD ResMed Inc. 5.7×
WST West Pharmaceutical Services, Inc. compare 7.9×
RGEN Repligen Corporation compare 13.6×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on RMD